MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/ehaf481

Медицинская библиотека · European heart journal · 2025

Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.

Chen Jing, Xu Changwu, Qiu Liqiang, Li Bin, Yao Wei, Wu Hui, Hu Longcai, Xu Guang, Zhu Dongmei, Li Zhengzai, Wu Xiaolin, Xiao Chuang, Liu Bo, Shen Xiuzhen, Deng Zhaowu, Zhuo Chaogui, Su Huajun, Yang Keping, Zhang Youen, Zhang Meichun, Li Chang, Lv Xuexiang, Hong Lifeng, Guo Fan, Wu Xingan, Xu Hao, Li Mingjian, He Liqun, Wu Wenjun, Lei Yuhua, Li Dongsheng, Li Huoping, Chen Shaoze, Bao Hong, Xiong Xuguang, Liu Bo, Yang Guokang, Chen Jinke, Lan Xiao, Zheng Qibin, Yang Guanglong, Zhang Mingxi, Yang Jian, Jiang Hong

СтатьяРандомизированное исследованиеМногоцентровое исследованиеСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND AND AIMS: The beneficial effect of pre-treatment with unfractionated heparin (UFH) at first medical contact (FMC) before primary percutaneous coronary intervention (PPCI) in all-comers with ST-elevation myocardial infarction (STEMI) remains uncertain.

METHODS

HELP-PCI was an investigator-initiated, randomized controlled trial conducted at 36 clinical centres in China. Patients with STEMI presenting ≤12 h after symptom onset undergoing PPCI were randomly assigned (1:1) to intravenous administration with UFH (100 U/kg) at FMC or in the Cath Lab through a catheter sheath. The primary endpoint was Thrombolysis in Myocardial Infarction flow grade (TFG)-3 of infarct-related artery (IRA) at diagnostic angiography before PPCI. The secondary outcome was complete epicardial and myocardial reperfusion after PPCI and major adverse cardiac and cerebrovascular events (MACCE; defined as the composite of all-cause death, cardiac death, heart failure hospitalizations, re-infarction, stent thrombosis, unplanned revascularization, and stroke) at 12 months. Safety outcome was 30-day Bleeding Academic Research Consortium (BARC) type ≥2 bleeding.

RESULTS

A total of 999 patients with STEMI undergoing PPCI were randomly assigned to receive either UFH administration at FMC (n = 505) or in the Cath Lab (n = 494). Pre-treated population at FMC showed a higher frequency of TFG-3 of IRA compared with the Cath Lab group (23.6% vs 17.6%; odds ratio, 1.44; 95% confidence interval, 1.06-1.97; P = .02). There were no significant differences in secondary endpoints or in the safety endpoint, including 12-month MACCE, complete epicardial and myocardial reperfusion, and major bleeding.

CONCLUSIONS

Pre-treatment with loading-dose UFH at FMC was associated with an improvement of spontaneous reperfusion of IRA without increasing the risk of major bleeding.

Для цитирования: Chen Jing, Xu Changwu, Qiu Liqiang, Li Bin, Yao Wei, Wu Hui, Hu Longcai, Xu Guang, Zhu Dongmei, Li Zhengzai, Wu Xiaolin, Xiao Chuang, Liu Bo, Shen Xiuzhen, Deng Zhaowu, Zhuo Chaogui, Su Huajun, Yang Keping, Zhang Youen, Zhang Meichun, Li Chang, Lv Xuexiang, Hong Lifeng, Guo Fan, Wu Xingan, Xu Hao, Li Mingjian, He Liqun, Wu Wenjun, Lei Yuhua, Li Dongsheng, Li Huoping, Chen Shaoze, Bao Hong, Xiong Xuguang, Liu Bo, Yang Guokang, Chen Jinke, Lan Xiao, Zheng Qibin, Yang Guanglong, Zhang Mingxi, Yang Jian, Jiang Hong. Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.. European heart journal. 2025. DOI: 10.1093/eurheartj/ehaf481.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.